Daclizumab: outcome of phase III trials and mechanism of action. Double Therapy and the Triple Therapy Study Groups.

Flavio Vincenti,B. Nashan,Susan Light
DOI: https://doi.org/10.1016/S0041-1345(98)00571-5
IF: 1.014
1998-08-01
Transplantation Proceedings
Abstract:
What problem does this paper attempt to address?